Lars Kristian Munck
Quick facts
Marketed products
- Oral chenodeoxycholic acid stimulation · Hepatology / Gastroenterology
Chenodeoxycholic acid is a bile acid that activates farnesoid X receptor (FXR) and TGR5 signaling pathways to regulate bile acid metabolism and reduce cholestasis.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors: